The role of tonic immobility during re-experiencing trauma in PTSD treatment
Loading...
Date
Authors
Burg, N.C. Nadine
Hagenaars, M.A. Muriel
Jongh, A. Ad
Minnen, A. Agnes
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Tonic immobility (TI) is a profound paralysis that may occur during extreme stress. Previous studies have found that TI during trauma was associated with poorer recovery from posttraumatic stress disorder (PTSD). Importantly, TI can re-occur during re-experiencing the trauma (TIre-exp). It is unclear whether TIre-exp also hinders recovery from PTSD or declines along with other PTSD symptoms after treatment. We examined whether pre-treatment self-reported TIre-exp would predict PTSD symptoms after trauma-focused treatment, including related constructs as depression and dissociation. and investigated pre- to post-treatment changes in TIre-exp. We also explored individual differences in TIre-exp course. A total of 257 patients with PTSD, referred to a clinic for intensive trauma-focused therapy, completed measures for PTSD symptoms and TIre-exp at pre- and posttreatment, and potential confounding variables (dissociative tendencies, somatoform dissociation, dissociative subtype, and depression) at pre-treatment. Higher pre-treatment TIre-exp predicted elevated post-treatment PTSD symptoms, but not after controlling for potentially confounding constructs. Overall, TIre-exp decreased from pre- to post-treatment, and a greater decrease in TIre-exp was associated with a greater decrease in PTSD symptoms. However, four distinct clusters could be identified, which differed in TIre-exp course: High-stable, High-decrease, Moderate and Low TIre-exp. End-state was worse for patients in the High-stable and Moderate clusters. Thus, in the general sample, pre-treatment TIre-exp was not associated with reduced recovery, and TIre-exp generally decreased after treatment, suggesting that TIre-exp may be related to the PTSD symptomatology, responding well to trauma-focused CBT treatment. However, TIre-exp may not decline in specific patient groups. Future research may address how TIre-exp can be targeted for these patients.
